Macquarie Group
PHXM

Macquarie Group’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Macquarie Group’s Portfolio PHXM Stock Details PHXM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-60
Closed -$13K – 2419
2017
Q4 		$13K Buy
+60
New +$13K ﹤0.01% 2236